Simone Claudiani

7PUBLICATIONS
7CO-AUTHORS
Main group metal chemistryPredictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Transfusion-Independent iron overload in SF3B1-mutant myelodysplastic syndrome case report.

|May 30, 2026
Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFR.

|Mar 04, 2024
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.

Simone Claudiani, Lynette Chee, Fiona Fernando

|Feb 29, 2024
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance.

Simone Claudiani, Farhan Chughtai, Afzal Khan

|Dec 19, 2021
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors.

Simone Claudiani, Jane F Apperley, Eleanor L Parker

|Oct 28, 2021
Is COVID-19 less severe in CML patients than in those with other haematological cancers?

Simone Claudiani

Pageof 2

Frequent Collaborators

4 joint publications

Andrew J Innes

2 joint publications

Jamshid Khorashad

1 joint publications

George Nesr

1 joint publications

Farhan Chughtai